Zinc acetate lozenges may shorten common cold duration by up to 40%: [eLetter]

Research output: Contribution to journalComment/debateScientific

Abstract

The systematic review by Dr. Science et al. has a number of problems. ...
Even though we need further research to find out what the optimal lozenge compositions and treatment strategies are, the great benefit and the minimal adverse effects in the zinc acetate trials gives a strong rationale for physicians to suggest common cold patients to test zinc acetate lozenges (about 80 mg/day of zinc).
Original languageEnglish
JournalCMAJ
Volume184
Issue number10
ISSN0820-3946
Publication statusPublished - 2012
MoE publication typeB1 Journal article

Fields of Science

  • 3125 Otorhinolaryngology, ophthalmology
  • 317 Pharmacy
  • upper respiratory infections
  • zinc lozenges
  • RANDOMIZED TRIALS
  • Systematic review

Cite this